Correlation Between Akero Therapeutics and Biomea Fusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Biomea Fusion, you can compare the effects of market volatilities on Akero Therapeutics and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Biomea Fusion.

Diversification Opportunities for Akero Therapeutics and Biomea Fusion

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Akero and Biomea is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Biomea Fusion go up and down completely randomly.

Pair Corralation between Akero Therapeutics and Biomea Fusion

Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.79 times more return on investment than Biomea Fusion. However, Akero Therapeutics is 1.26 times less risky than Biomea Fusion. It trades about 0.1 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.51 per unit of risk. If you would invest  2,971  in Akero Therapeutics on August 28, 2024 and sell it today you would earn a total of  206.00  from holding Akero Therapeutics or generate 6.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Akero Therapeutics  vs.  Biomea Fusion

 Performance 
       Timeline  
Akero Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Biomea Fusion 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Biomea Fusion is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Akero Therapeutics and Biomea Fusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akero Therapeutics and Biomea Fusion

The main advantage of trading using opposite Akero Therapeutics and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.
The idea behind Akero Therapeutics and Biomea Fusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets